R&D

Research Platform

Research Strength

Research Platform

Since its inception in September 2021, the R&D Center has established a series of specialized platforms, including an API development platform, a formulation development platform, a quality research platform, a new drug R&D platform, a project management and regulatory affairs platform, and a clinical research platform. To date, the Center employs over 100 R&D personnel, with more than 30% holding master’s or doctoral degrees, and is advancing more than ten innovative drug candidates, over 50 high-end generic formulations, and more than 30 API and excipient projects — forming a tiered development structure. The Center has also progressively built an R&D pipeline centered on products across multiple therapeutic areas, including antiviral, anti-infective, cardiovascular and cerebrovascular, endocrine, oncology, metabolic disorders (e.g., diabetes, dyslipidemia, hypertension, hyperuricemia), and immunology.
100 +

R&D personnel

10 +

Research and Development of Innovative Drug Projects

50 +

High-end Generic Drug Project

30 +

Raw and Auxiliary Materials Project

Raw Material Development Platform

Raw Material Development Platform

Active pharmaceutical ingredient and excipient development and industrialization platform.

Focusing on the synthesis of complex compounds, their industrial-scale conversion, and green chemistry technologies, we provide efficient and environmentally friendly raw-material solutions.

New Drug Development Platform

New Drug Development Platform

Core platform for the design and development of Class 1 and Class 2 innovative drugs.

Focusing on the discovery of novel drug targets, exploring cutting-edge therapies, and driving breakthroughs in the transition of innovative medicines from research and development to clinical application.

Formulation Development Platform

Formulation Development Platform

Chemical generic drug and new drug formulation development platform.

Overcome challenging formulation‑related technical hurdles and develop pharmaceutical products that are more patient‑friendly, safer, and more effective.

Quality Research Platform

Quality Research Platform

A platform supporting pharmaceutical quality research and end-to-end quality control.

Collaborate with all process departments to develop analytical methods for new product varieties and establish quality standards, ensuring consistent and reliable drug quality throughout the entire lifecycle.

Clinical Medicine Platform

Clinical Medicine Platform

A specialized management platform for clinical drug research.

Responsible for the evaluation, development, and full‑cycle management of clinical protocols for Class 3 and Class 4 generic drugs as well as innovative medicines, ensuring that clinical studies are conducted in compliance with regulations and with high efficiency.

Project Management and Registration Platform

Project Management and Registration Platform

A unified platform for end-to-end project management and regulatory submission coordination.

Responsible for monitoring project progress and quality, reviewing R&D data and regulatory submission documents, and ensuring project quality as well as compliance with applicable laws and regulations.

Coordinate the preparation of project submission documents and regulatory registration activities to facilitate the smooth attainment of marketing authorization.

< 1 >